title: Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men.
abstract: OBJECTIVE
  Adiponectin is an adipocyte-derived, antiatherogenic protein that is present in plasma as a large multimeric structure of high molecular weight (HMW) and in a trimer or hexamer form (non-HMW). The biological activities of these isoforms have not yet been elucidated. We therefore examined the effect of these isoforms on endothelial function in healthy young men.
  
  
  METHODS
  One hundred apparently healthy young men without overt cardiovascular disease (mean age 30 years) were recruited in this cross-sectional study based on voluntary enrollment.
  
  
  METHODS
  We evaluated endothelial function estimated by flow-mediated dilatation (FMD) of the brachial artery during reactive hyperaemia, and measured total and HMW adiponectin levels.
  
  
  RESULTS
  Both HMW and non-HMW adiponectin levels showed a significant, inverse correlation with body mass index (BMI). FMD was significantly correlated with fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), malondialdehyde-modified low density lipoprotein (MDA-LDL), LDL particle size, and HMW adiponectin (r = 0.320, P = 0.001), but not non-HMW adiponectin (r = 0.125, P = 0.22). In multivariate analysis, HMW adiponectin and MDA-LDL were selected as independent factors capable of influencing FMD. No variables determined nitroglycerin-induced dilatation.
  
  
  CONCLUSIONS
  These results suggest that even in young men, plasma adiponectin levels can predict endothelial dysfunction before any overt vascular disease has occurred. HMW adiponectin may be more useful as a marker of endothelial dysfunction than total adiponectin.
authors.affiliation: Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsusumai-cho, Showa-ku, Nagoya 466-8550, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Torigoe
authors.forename: Hideo
authors.initials: H
authors.lastname: Matsui
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Ogawa
authors.forename: Hisashi
authors.initials: H
authors.lastname: Murakami
authors.forename: Ryuichiro
authors.initials: R
authors.lastname: Murakami
authors.forename: Xian Wu
authors.initials: XW
authors.lastname: Cheng
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Numaguchi
authors.forename: Toyoaki
authors.initials: T
authors.lastname: Murohara
authors.forename: Kenji
authors.initials: K
authors.lastname: Okumura
mesh_terms: D052242:Adiponectin / Q000097:blood* / Q000737:chemistry; D000328:Adult; D001916:Brachial Artery / Q000000981:diagnostic imaging / Q000502:physiology; D003430:Cross-Sectional Studies; D004730:Endothelium, Vascular / Q000502:physiology*; D006801:Humans; D006940:Hyperemia / Q000097:blood / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008077:Lipoproteins, LDL / Q000032:analysis; D008297:Male; D008315:Malondialdehyde / Q000031:analogs & derivatives / Q000032:analysis; D008970:Molecular Weight; D015999:Multivariate Analysis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D005996:Nitroglycerin; D012039:Regional Blood Flow; D014463:Ultrasonography; D014664:Vasodilation
chemical_list: D052242:Adiponectin; D007328:Insulin; D008077:Lipoproteins, LDL; C502964:malondialdehyde-low density lipoprotein, mouse; D008315:Malondialdehyde; D019001:Nitric Oxide Synthase; D005996:Nitroglycerin